246
Views
2
CrossRef citations to date
0
Altmetric
Articles

Magnesium Bioavailability and Tolerability Do Not Differ between Two Supplements with Different Release Properties

, PhD, , PhD, , PhD & , PhD

References

  • Altura BT, Wilimzig C, Trnovec T, Nyulassy S, Altura BM. 1994. Comparative effects of a Mg-enriched diet and different orally administered magnesium oxide preparations on ionized Mg, Mg metabolism and electrolytes in serum of human volunteers. J Am Coll Nutr. 13(5):447–54.
  • Ayuk J, Gittoes NJ. 2014. Contemporary view of the clinical relevance of magnesium homeostasis. Ann Clin Biochem. 51(Pt 2):179–88. doi:10.1177/0004563213517628.
  • Bashir Y, Sneddon JF, Staunton HA, Haywood GA, Simpson IA, McKenna WJ, Camm AJ. 1993. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 72(15):1156–62.
  • Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. 1985. Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed). 291(6490):235–8. doi:10.1136/bmj.291.6490.235.
  • Classen O, Fischer H, Classen HG. 1986. Magnesiummangel und magnesiumtherapie bei kindern mit funktionellen und neurovegetativen beschwerden. Kinderarzt. 17:1565–8.
  • Coudray C, Feillet-Coudray C, Rambeau M, Tressol JC, Gueux E, Mazur A, Rayssiguier Y. 2006. The effect of aging on intestinal absorption and status of calcium, magnesium, zinc, and copper in rats: a stable isotope study. J Trace Elem Med Biol. 20(2):73–81. doi:10.1016/j.jtemb.2005.10.007.
  • Daly NM, Allen KGD, Harris M. 1990. Magnesium supplementation and blood pressure in borderline hypertensive subjects: a double blind study. Magnes Bull. 12:149–54.
  • de Baaij JHF, Hoenderop JGJ, Bindels R. 2015. Magnesium in man: implications for health and disease. Physiol Rev. 95(1):1–46. doi:10.1152/physrev.00012.2014.
  • Deng X, Song Y, Manson JE, Signorello LB, Zhang SM, Shrubsole MJ, Ness RM, Seidner DL, Dai Q. 2013. Magnesium, vitamin D status and mortality: results from US National Health and Nutrition Examination Survey (NHANES) 2001 to 2006 and NHANES III. BMC Med. 11:187.
  • Dolberg MKB, Nielsen LP, Dahl R. 2017. Pharmacokinetic profile of oral magnesium hydroxide. Basic Clin Pharmacol Toxicol. 120(3):264–9. doi:10.1111/bcpt.12642.
  • European Food Safety Authority, editor. 2006. Tolerable upper intake levels for vitamins and minerals. Parma (Italy): European Food Safety Authority.
  • European Food Safety Authority (EFSA). 2015. Scientific opinion on dietary reference values for magnesium. EFSA J. 13:4186.
  • Fehlinger R, Kemnitz C, Stephan A, Fauk D, Franke L, Ruth F, Glatzel E. 1988. Clinical study of the effectiveness of pyrrolidone carboxylic acid magnesium in the treatment of patients with chronic tetanic syndrome. Curr Ther Res. 43:160–70.
  • Fine KD, Santa Ana CA, Porter JL, Fordtran JS. 1991. Intestinal absorption of magnesium from food and supplements. J Clin Invest. 88(2):396–402. doi:10.1172/JCI115317.
  • Firoz M, Graber M. 2001. Bioavallability of US commercial magnesium preparations. Magnes Res. 14(4):257–62.
  • Graham LA, Caesar JJ, Burgen AS. 1960. Gastrointestinal absorption and excretion of Mg28 in man. Metab Clin Exp. 9:646–59.
  • Gröber U, Schmidt J, Kisters K. 2015. Magnesium in prevention and therapy. Nutrients. 7(9):8199–226. doi:10.3390/nu7095388.
  • Gullestad L, Oystein Dolva L, Birkeland K, Falch D, Fagertun H, Kjekshus J. 1991. Oral versus intravenous magnesium supplementation in patients with magnesium deficiency. Magnes Trace Elem. 10(1):11–6.
  • Heinemann M, Willers J, Bitterlich N, Hahn A. 2015. Verwendung von nahrungsergänzungsmitteln mit vitaminen und mineralstoffen – ergebnisse einer deutschlandweiten verbraucherbefragung. J Verbr Lebensm. 10(2):131–42. doi:10.1007/s00003-014-0912-x.
  • Institute of Medicine (IoM). 1997. Dietary reference intakes: calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy Press.
  • Kappeler D, Heimbeck I, Herpich C, Naue N, Höfler J, Timmer W, Michalke B. 2017. Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study. BMC Nutr. 3:7.
  • Karagülle O, Kleczka T, Vidal C, Candir F, Gundermann G, Külpmann WR, Gehrke A, Gutenbrunner C. 2006. Magnesium absorption from mineral waters of different magnesium content in healthy subjects. Complement Med Res. 13:9–14. doi:10.1159/000090016.
  • Marken PA, Wayne Weart C, Stier Carson D, Gums JG, Fernanda Lopes-Virella M. 1989. Effects of magnesium oxide on the lipid profile of healthy volunteers. Atherosclerosis. 77(1):37–42. doi:10.1016/0021-9150(89)90007-5.
  • Max-Rubner-Institut. 2008. Ergebnisbericht teil 2, nationale verzehrsstudie II. In: Lebensmittel-warenkunde für einsteiger [Internet]. Karlsruhe, Germany: Max-Rubner-Institut, Bundesforschungsinstitut für Ernährung und Lebensmittel. p. 121–48 [cited 2016 Aug 4]. http://link.springer.com/chapter/10.1007/978-3-662-46280-5_6
  • Mühlbauer B, Schwenk M, Coram WM, Antonin KH, Etienne P, Bieck PR, Douglas FL. 1991. Magnesium-L-aspartate-HCl and magnesium-oxide: bioavailability in healthy volunteers. Eur J Clin Pharmacol. 40(4):437–8.
  • Nadler JL, Malayan S, Luong H, Shaw S, Natarajan RD, Rude RK. 1992. Intracellular free magnesium deficiency plays a key role in increased platelet reactivity in type II diabetes mellitus. Diabetes Care. 15(7):835–841. doi:10.2337/diacare.15.7.835.
  • Paolisso G, Sgambato S, Gambardella A, Pizza G, Tesauro P, Varricchio M, D’Onofrio F. 1992. Daily magnesium supplements improve glucose handling in elderly subjects. Am J Clin Nutr. 55(6):1161–7. doi:10.1093/ajcn/55.6.1161.
  • Plum-Wirell M, Stegmayr BG, Wester PO. 1994. Nutritional magnesium supplementation does not change blood pressure nor serum or muscle potassium and magnesium in untreated hypertension. A double-blind crossover study. Magnes Res. 7(3-4):277–83.
  • Quamme GA. 2008. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol. 24(2):230–5. doi:10.1097/MOG.0b013e3282f37b59.
  • Quamme GA, Dirks JH. 1986. The physiology of renal magnesium handling. Renal Physiol. 9(5):257–69.
  • Ranade VV, Somberg JC. 2001. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am J Ther. 8(5):345–57.
  • Rasmussen HS, Aurup P, Goldstein K, McNair P, Mortensen PB, Larsen OG, Lawaetz H. 1989. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease: a double-blind, placebo controlled study. Arch Intern Med. 149(5):1050–3.
  • Ricci JM, Hariharan S, Helfgott A, Reed K, O’Sullivan MJ. 1991. Oral tocolysis with magnesium chloride: a randomized controlled prospective clinical trial. Am J Obstet Gynecol. 165(3):603–10.
  • Rüddel H, Werner C, Ising H. 1990. Impact of magnesium supplementation on performance data in young swimmers. Magnes Res. 3(2):103–7.
  • Rude RK. 2012. Magnesium. In: Ross AC, Caballero B, Cousins RJ, Tucker KL, Ziegler TR, editors. Modern nutrition in health and disease. 11th ed. Baltimore (MA): Lippincott Williams & Wilkins. p. 159–75.
  • Saris N-E, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. 2000. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta. 294:1–26.
  • Schimatschek H, Hipp S, Rempis R, Wiesinger W, Classen H. 2001. Magnesiummangel bei adipösen kindern? Kinder Jugendmed. 4:105–108.
  • Schimatschek HF, Classen HG, Baerlocher K, Thöni H. 1997. Hypomagnesiämie und funktionell-neurovegetative beschwerden bei kindern: eine doppelblindstudie mit magnesium-L-aspartat-hydrochlorid. Kinderarzt. 28:196–203.
  • Schneider I, Greupner T, Hahn A. 2017. Magnesium bioavailability from mineral waters with different mineralization levels in comparison to bread and a supplement. Food Nutr Res. 61(1):1384686. doi:10.1080/16546628.2017.1384686.
  • Schuchardt JP, Hahn A. 2017. Intestinal absorption and factors influencing bioavailability of magnesium-an update. Curr Nutr Food Sci. 13(4):260–78. doi:10.2174/1573401313666170427162740.
  • Schweigel M, Martens H. 2000. Magnesium transport in the gastrointestinal tract. Front Biosci. 5(3):d666–77. doi:10.2741/Schweigel.
  • Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. 2005. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 28(6):1438–44. doi:10.2337/diacare.28.6.1438.
  • Spätling L, Bubeck J, Schulz U, Wendt B, Teubner S, Disch-Hesse G, Siegmund-Schultze E, Classen H. 1998. Magnesiumsupplementation in der stillzeit?. Geburtsh Frauenheilk. 58(10):561–5. doi:10.1055/s-2007-1022761.
  • Spätling L, Spätling G. 1988. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol. 95(2):120–5.
  • Spencer H, Fuller H, Norris C, Williams D. 1994. Effect of magnesium on the intestinal absorption of calcium in man. J Am Coll Nutr. 13(5):485–92.
  • Stendig-Lindberg G, Tepper R, Leichter I. 1993. Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis. Magnes Res. 6(2):155–63.
  • Topf JM, Murray PT. 2003. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. 4(2):195–206. doi:10.1023/A:1022950321817.
  • Verhas M, Gueronniere V. D L, Grognet JM, Paternot J, Hermanne A, Winkel PD, Gheldof R, Martin P, Fantino M, Rayssiguier Y. 2002. Original communications-magnesium bioavailability from mineral water. A study in adult men. Eur J Clin Nutr. 56(5):442–7. doi:10.1038/sj.ejcn.1601333.
  • Walker AF, Marakis G, Christie S, Byng M. 2003. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 16(3):183–91.
  • Whang R, Hampton EM, Whang DD. 1994. Magnesium homeostasis and clinical disorders of magnesium deficiency. Ann Pharmacother. 28(2):220–26. doi:10.1177/106002809402800213.
  • Widman L, Wester PO, Stegmayr BK, Wirell M. 1993. The dose-dependent reduction in blood pressure through administration of magnesium a double blind placebo controlled cross-over study. Am J Hypertens. 6(1):41–5. doi:10.1093/ajh/6.1.41.
  • Zemel PC, Zemel MB, Urberg M, Douglas FL, Geiser R, Sowers JR. 1990. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr. 51(4):665–9. doi:10.1093/ajcn/51.4.665.
  • Zhang X, Del Gobbo LC, Hruby A, Rosanoff A, He K, Dai Q, Costello RB, Zhang W, Song Y. 2016. The circulating concentration and 24-h urine excretion of magnesium dose- and time-dependently respond to oral magnesium supplementation in a meta-analysis of randomized controlled trials. J Nutr. 146(3):595–602.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.